{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:39:42Z","timestamp":1790962782066,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Methodist Hospital Research Institute"},{"name":"EU Commission"},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Department 11 \u201cCulture-Education-University-Research-Technological Innovation \u2014 Higher Education\u201d of Calabria Region (POR Calabria FSE","award":["2007\/2013"],"award-info":[{"award-number":["2007\/2013"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jconrel.2013.06.012","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T15:50:38Z","timestamp":1371570638000},"page":"460-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity"],"prefix":"10.1016","volume":"170","author":[{"given":"Daniele","family":"Di Mascolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"J. Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Aryal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricela R.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Candeloro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Guindani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willa A.","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Decuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2013.06.012_bb0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nm.3114","article-title":"Turning off the inflammatory, but not the metabolic, flames","volume":"19","author":"Calay","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0015","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nm1102-1257","article-title":"Stabilization of atherosclerotic plaques: new mechanisms and clinical targets","volume":"8","author":"Libby","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI10370","article-title":"Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice","volume":"106","author":"Li","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0025","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1172\/JCI31561","article-title":"Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones","volume":"117","author":"Hevener","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tem.2012.03.001","article-title":"Thiazolidinediones and PPARgamma agonists: time for a reassessment","volume":"23","author":"Cariou","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0035","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","article-title":"The many faces of PPARgamma","volume":"123","author":"Lehrke","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0040","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1161\/CIRCULATIONAHA.111.056309","article-title":"Mice with cardiac overexpression of peroxisome proliferator-activated receptor gamma have impaired repolarization and spontaneous fatal ventricular arrhythmias","volume":"124","author":"Morrow","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0045","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0050","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jmri.20866","article-title":"Molecular imaging and therapy of atherosclerosis with targeted nanoparticles","volume":"25","author":"Wickline","year":"2007","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc1566","article-title":"Cancer nanotechnology: opportunities and challenges","volume":"5","author":"Ferrari","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11095-008-9697-x","article-title":"Intravascular delivery of particulate systems: does geometry really matter?","volume":"26","author":"Decuzzi","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0065","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/smll.201100442","article-title":"More effective nanomedicines through particle design","volume":"7","author":"Wang","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jconrel.2009.10.014","article-title":"Size and shape effects in the biodistribution of intravascularly injected particles","volume":"141","author":"Decuzzi","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0075","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1529\/biophysj.107.120238","article-title":"The receptor-mediated endocytosis of nonspherical particles","volume":"94","author":"Decuzzi","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0080","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1073\/pnas.0600997103","article-title":"Role of target geometry in phagocytosis","volume":"103","author":"Champion","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0085","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.0801763105","article-title":"The effect of particle design on cellular internalization pathways","volume":"105","author":"Gratton","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nnano.2008.30","article-title":"Nanoparticle-mediated cellular response is size-dependent","volume":"3","author":"Jiang","year":"2008","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2008.09.073","article-title":"A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles","volume":"133","author":"Cohen-Sela","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-3659(97)00149-1","article-title":"Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1, 2-dipalmitoylphosphatidylcholine","volume":"51","author":"Evora","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","article-title":"Biodegradable polymeric nanoparticles as drug delivery devices","volume":"70","author":"Soppimath","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2013.03.010","article-title":"Immune system targeting by biodegradable nanoparticles for cancer vaccines","volume":"168","author":"Silva","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0115","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(07)61514-1","article-title":"Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials","volume":"370","author":"Lago","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-3659(01)00505-3","article-title":"Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery","volume":"78","author":"Lestini","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0125","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd3578","article-title":"Perspectives and opportunities for nanomedicine in the management of atherosclerosis","volume":"10","author":"Lobatto","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2011.12.014","article-title":"Drug targeting systems for inflammatory disease: one for all, all for one","volume":"161","author":"Crielaard","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/10837450802498894","article-title":"Co-solvent solubilization of some poorly-soluble antidiabetic drugs","volume":"14","author":"Seedher","year":"2009","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0140","first-page":"577","article-title":"Enhancement of solubility and dissolution of rosiglitazone by solid dispersion (kneading) technique","volume":"2","author":"Jagtap","year":"2012","journal-title":"Am. J. PharmTech Res."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0155","series-title":"Royal Society of Chemistry (Great Britain), Practical Statistics for the Analytical Scientist: A Bench Guide","author":"Ellison","year":"2009"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-5173(99)00187-8","article-title":"Preparation of poly(dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method","volume":"187","author":"Murakami","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2012.10.015","article-title":"Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres\u2014a review","volume":"165","author":"Versypt","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0170","series-title":"Fundamentals and Applications of Controlled Release Drug Delivery","first-page":"19","article-title":"Overview of controlled release mechanisms","author":"Siegel","year":"2012"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0175","first-page":"279","article-title":"Characterization of degradation behavior for PLGA in various pH condition by simple liquid chromatography method","volume":"15","author":"Yoo","year":"2005","journal-title":"Biomed. Mater. Eng."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jchromb.2007.07.013","article-title":"Investigation of the lipophilic behaviour of some thiazolidinediones: relationships with PPAR-\u03b3 activity","volume":"857","author":"Giaginis","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0190","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.2337\/diabetes.54.9.2514","article-title":"Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver","volume":"54","author":"Park","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2013.06.012_bb0195","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1161\/ATVBAHA.112.253823","article-title":"Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia","volume":"32","author":"Nagahama","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2013.06.012_bb0200","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1476-5381.2010.01057.x","article-title":"Effects of 15d-PGJ2-loaded poly(D, L-lactide-co-glycolide) nanocapsules on inflammation","volume":"162","author":"Alves","year":"2011","journal-title":"Br. J. Pharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T01:55:17Z","timestamp":1539568517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913003465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0168365913003465"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.06.012","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}